Skip to main content

Table 4 Cumulative numbers of breast cancer cases observed with and without screening

From: Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time

Age range observed, years

Years of follow-up

Number of cases

Observed percentage excess

  

Without screening

With screening

incidence With screening

50-69

5

50,270

102,380

102

 

10

101,440

153,460

51

 

15

152,160

226,680

49

 

20

202,880

277,060

37

 

25

253,600

304,080

20

 

30

304,320

351,260

15

50-74

5

65,300

113,400

74

 

10

130,600

170,500

31

 

15

195,900

250,100

28

 

20

261,200

307,675

18

 

25

326,500

341,975

5

 

30

391,800

402,100

3

50-79

5

77,980

126,069

62

 

10

155,960

195,018

25

 

15

233,940

285,435

22

 

20

311,920

354,714

14

 

25

389,900

400,239

3

 

30

467,880

472,014

1